Crossref journal-article
American Society for Microbiology
Journal of Virology (235)
Abstract

ABSTRACT The oncoproteins E6 and E7 of human papillomavirus type 38 (HPV38) display several transforming activities in vitro, including immortalization of primary human keratinocytes. To evaluate the oncogenic activities of the viral proteins in an in vivo model, we generated transgenic mice expressing HPV38 E6 and E7 under the control of the bovine homologue of the human keratin 10 (K10) promoter. Two distinct lines of HPV38 E6/E7-expressing transgenic mice that express the viral genes at different levels were obtained. In both lines, HPV38 E6 and E7 induced cellular proliferation, hyperplasia, and dysplasia in the epidermis. The rate of occurrence of these events was proportional to the levels of HPV38 E6 and E7 expression in the two transgenic lines. Exposure of the epidermis of nontransgenic mice to UV led to p21 WAF1 accumulation and cell cycle arrest. In contrast, keratinocytes from transgenic mice continued to proliferate and were not positive for p21 WAF1 , indicating that cell cycle checkpoints are altered in keratinocytes expressing the viral genes. Although the HPV38 E6/E7-expressing transgenic mice did not develop spontaneous tumors during their life span, two-stage carcinogen treatment led to a high incidence of papillomas, keratoacanthomas, and squamous-cell carcinomas in HPV38 mice compared with nontransgenic animals. Together, these data show that HPV38 E6 and E7 display transforming properties in vivo, providing further support for the role of HPV38 in carcinogenesis.

Bibliography

Dong, W., Kloz, U., Accardi, R., Caldeira, S., Tong, W.-M., Wang, Z.-Q., Jansen, L., Dürst, M., Sylla, B. S., Gissmann, L., & Tommasino, M. (2005). Skin Hyperproliferation and Susceptibility to Chemical Carcinogenesis in Transgenic Mice Expressing E6 and E7 of Human Papillomavirus Type 38. Journal of Virology, 79(23), 14899–14908.

Authors 11
  1. Wen Dong (first)
  2. Ulrich Kloz (additional)
  3. Rosita Accardi (additional)
  4. Sandra Caldeira (additional)
  5. Wei-Min Tong (additional)
  6. Zhao-Qi Wang (additional)
  7. Lars Jansen (additional)
  8. Matthias Dürst (additional)
  9. Bakary S. Sylla (additional)
  10. Lutz Gissmann (additional)
  11. Massimo Tommasino (additional)
References 36 Referenced 65
  1. 10.1128/mcb.14.12.8250-8258.1994
  2. 10.1002/j.1460-2075.1989.tb03355.x
  3. 10.1038/nrc1253
  4. Boyle, J., R. M. MacKie, J. D. Briggs, B. J. Junor, and T. C. Aitchison. 1984. Cancer warts, and sunshine in renal transplant patients. A case-control study. Lanceti:702-705. / Lancet (1984)
  5. 10.1016/j.canlet.2003.12.003
  6. 10.1128/JVI.77.3.2195-2206.2003
  7. 10.1016/j.virol.2004.03.033
  8. 10.1016/0042-6822(92)90688-L
  9. Eckert, R. L., J. F. Crish, S. Balasubramanian, and E. A. Rorke. 2000. Transgenic animal models of human papillomavirus-dependent disease. Int. J. Oncol.16:853-870. / Int. J. Oncol. (2000)
  10. 10.3181/00379727-206-43720A
  11. 10.1097/00007890-199003000-00006
  12. 10.1128/JVI.78.9.4797-4805.2004
  13. 10.1128/jvi.62.10.3655-3661.1988
  14. Jablonska, S., J. Dabrowski, and K. Jakubowicz. 1972. Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res.32:583-589. / Cancer Res. (1972)
  15. 10.1101/gad.182100
  16. 10.1006/scbi.1999.0143
  17. 10.1158/1055-9965.EPI-04-0551
  18. 10.1073/pnas.90.12.5583
  19. 10.1074/jbc.M212696200
  20. 10.1016/S0738-081X(96)00169-1
  21. 10.1128/JVI.78.24.13769-13778.2004
  22. 10.1038/sj.onc.1205617
  23. 10.1038/sj.onc.1204869
  24. 10.1128/JVI.78.21.11451-11460.2004
  25. 10.1038/sj.onc.1204860
  26. 10.1128/JVI.77.12.6957-6964.2003
  27. Orth, G., S. Jablonska, M. Jarzabek-Chorzelska, S. Obalek, G. Rzesa, M. Favre, and O. Croissant. 1979. Characteristics of the lesions and risk of malignant conversion associated with the type of human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res.39:1074-1082. / Cancer Res. (1979)
  28. Pfister, H. 2003. Chapter 8: human papillomavirus and skin cancer. J. Natl. Cancer Inst. Monogr.31:52-56. / J. Natl. Cancer Inst. Monogr. (2003)
  29. 10.1158/0008-5472.CAN-04-3263
  30. 10.1006/viro.1999.0106
  31. 10.1128/JVI.73.7.5887-5893.1999
  32. 10.1111/j.1440-0960.1976.tb00798.x
  33. Walder, B. K., M. R. Robertson, and D. Jeremy. 1971. Skin cancer and immunosuppression. Lancetii:1282-1283. / Lancet (1971)
  34. 10.1111/j.0022-202X.2005.23733.x
  35. Yamashita, T., K. Segawa, Y. Fujinaga, T. Nishikawa, and K. Fujinaga. 1993. Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8. Oncogene8:2433-2441. / Oncogene (1993)
  36. 10.1038/nrc798
Dates
Type When
Created 19 years, 9 months ago (Nov. 10, 2005, 1:12 p.m.)
Deposited 3 years, 5 months ago (March 5, 2022, 4:49 a.m.)
Indexed 11 months, 3 weeks ago (Sept. 9, 2024, 4:28 a.m.)
Issued 19 years, 8 months ago (Dec. 15, 2005)
Published 19 years, 8 months ago (Dec. 15, 2005)
Published Print 19 years, 8 months ago (Dec. 15, 2005)
Funders 0

None

@article{Dong_2005, title={Skin Hyperproliferation and Susceptibility to Chemical Carcinogenesis in Transgenic Mice Expressing E6 and E7 of Human Papillomavirus Type 38}, volume={79}, ISSN={1098-5514}, url={http://dx.doi.org/10.1128/jvi.79.23.14899-14908.2005}, DOI={10.1128/jvi.79.23.14899-14908.2005}, number={23}, journal={Journal of Virology}, publisher={American Society for Microbiology}, author={Dong, Wen and Kloz, Ulrich and Accardi, Rosita and Caldeira, Sandra and Tong, Wei-Min and Wang, Zhao-Qi and Jansen, Lars and Dürst, Matthias and Sylla, Bakary S. and Gissmann, Lutz and Tommasino, Massimo}, year={2005}, month=dec, pages={14899–14908} }